Smaller Pharma Firms Boost EU Innovation Presence
EU Regulation Continues To Promote SME Activity, Says EMA
Executive Summary
The 15-year anniversary report from the European Medicines Agency’s SME Office highlights the growing importance of smaller biopharmaceutical companies in the development, assessment and approval of innovative drugs.